ATC Group: B01AB04 Dalteparin

The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.

Position of B01AB04 in the ATC hierarchy

Level Code Title
1 B Blood and blood forming organs
2 B01 Antithrombotic agents
3 B01A Antithrombotic agents
4 B01AB Heparin group
5 B01AB04 Dalteparin

Defined daily dose

The DDD is the assumed average maintenance dose per day for a drug used for its main indication in adults. The DDD is a unit of measurement and does not necessarily reflect the recommended or Prescribed Daily Dose. Therapeutic doses for individual patients and patient groups will often differ from the DDD as they will be based on individual characteristics (such as age, weight, ethnic differences, type and severity of disease) and pharmacokinetic considerations.

Route Amount
PAREN - Parenteral 2,500 [iU]

Active ingredients in B01AB04

Active Ingredient Description
Dalteparin

Dalteparin is an antithrombotic agent, which acts mainly through its ability to potentiate the inhibition of Factor Xa and thrombin by antithrombin. It has a relatively higher ability to potentiate Factor Xa inhibition than to prolong plasma clotting time (APTT).

Related product monographs

Title Information Source Document Type  
FRAGMIN 10.000 IU Solution for injection Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC
FRAGMIN 100.000 IU Solution for injection Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC
FRAGMIN 12.500 IU Solution for injection Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC
FRAGMIN 2.500 IU Solution for injection Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC
FRAGMIN 5.000 IU Solution for injection Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC
FRAGMIN 7.500 IU Solution for injection Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC

Medicines in this ATC group

United States (US)

Austria (AT)

Brazil (BR)

Canada (CA)

Croatia (HR)

Estonia (EE)

Finland (FI)

France (FR)

Germany (DE)

Israel (IL)

Japan (JP)

Lithuania (LT)

Mexico (MX)

Netherlands (NL)

New Zealand (NZ)

Poland (PL)

Romania (RO)

Singapore (SG)

South Africa (ZA)

Spain (ES)

Tunisia (TN)

United Kingdom (UK)

Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.